Showing results (21-30 of 94) with videos related to
Sort By:
Pageof 10
Sheng Wu Gong Cheng Xue Bao = Chinese Journal of Biotechnology|April 8, 2014
[Preparation and penetrating effect of the polyarginine-enhanced green fluorescence protein fusion protein]Nan Zhang, Yin Bai, Jingzhuang Zhao, et al.International Immunopharmacology|June 21, 2019
Astragalus polysaccharides attenuated inflammation and balanced the gut microflora in mice challenged with Salmonella typhimuriumNa Dong, Xinran Li, Chenyu Xue, et al.Sheng Wu Gong Cheng Xue Bao = Chinese Journal of Biotechnology|November 8, 2013
[Anti-tumor efficacy of P53 with 9R cell-penetrating peptides]Yuan Liu, Rui Chen, Nan Zhang, et al.Immunology Letters|March 12, 2014
Genetically engineered Newcastle disease virus expressing interleukin 2 is a potential drug candidate for cancer immunotherapyFuliang Bai, Zeshan Niu, Hui Tian, et al.International Journal of Biological Macromolecules|May 27, 2019
An efficient large-scale refolding technique for recovering biologically active recombinant human FGF-21 from inclusion bodiesXianlong Ye, Dan Yu, Yunzhou Wu, et al.Molecular Immunology|October 5, 2013
Pharmacological efficacy of anti-IL-1β scFv, Fab and full-length antibodies in treatment of rheumatoid arthritisJianying Qi, Xianlong Ye, Guiping Ren, et al.Current Pharmaceutical Biotechnology|January 18, 2014
Construction of an anti-IL-1β scfv and TNFRI fusion protein and its therapeutic effect on RA mice modelFangming Kan, Guiping Ren, Mo Guo, et al.Molecular Biology Reports|September 18, 2021
FGF21 ameliorates hepatic fibrosis by multiple mechanismsFanrui Meng, Mir Hassan Khoso, Kai Kang, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|November 21, 2020
Fibroblast growth factor 21: a novel long-acting hypoglycemic drug for canine diabetesXinghao Jiang, Shijie Liu, Yaoqun Wang, et al.International Journal of Molecular Medicine|January 1, 2014
Chimeric anti-IL-17 full-length monoclonal antibody is a novel potential candidate for the treatment of rheumatoid arthritisFuliang Bai, Hui Tian, Zeshan Niu, et al.Pageof 10